High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy

Langerhans cell histiocytosis (LCH) is a rare hematologic neoplasm characterized by a clonal proliferation of Langerhans-like cells. Genomic profiling has identified recurrent somatic activating mutations in the mitogen-activated protein kinase pathway, which are targetable by small-molecule inhibit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Lee, Lynn H., Krupski, Christa, Clark, Jason, Wunderlich, Mark, Lorsbach, Robert B., Grimley, Michael S., Burwinkel, Matthew, Nelson, Adam, Kumar, Ashish R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042980/
https://ncbi.nlm.nih.gov/pubmed/32092141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019032367
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados